Kirsch KH - Search Results

1

Stabilization and productive positioning roles of the C2 domain of PTEN tumor suppressor.

Georgescu MM, Kirsch KH, Kaloudis P, Yang H, Pavletich NP, Hanafusa H. Georgescu MM, et al. Among authors: kirsch kh. Cancer Res. 2000 Dec 15;60(24):7033-8. Cancer Res. 2000. PMID: 11156408

2

The tumor-suppressor activity of PTEN is regulated by its carboxyl-terminal region.

Georgescu MM, Kirsch KH, Akagi T, Shishido T, Hanafusa H. Georgescu MM, et al. Among authors: kirsch kh. Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10182-7. doi: 10.1073/pnas.96.18.10182. Proc Natl Acad Sci U S A. 1999. PMID: 10468583 Free PMC article.

3

Direct binding of p130(Cas) to the guanine nucleotide exchange factor C3G.

Kirsch KH, Georgescu MM, Hanafusa H. Kirsch KH, et al. J Biol Chem. 1998 Oct 2;273(40):25673-9. doi: 10.1074/jbc.273.40.25673. J Biol Chem. 1998. PMID: 9748234 Free article.

4

Biological effects of c-Mer receptor tyrosine kinase in hematopoietic cells depend on the Grb2 binding site in the receptor and activation of NF-kappaB.

Georgescu MM, Kirsch KH, Shishido T, Zong C, Hanafusa H. Georgescu MM, et al. Among authors: kirsch kh. Mol Cell Biol. 1999 Feb;19(2):1171-81. doi: 10.1128/MCB.19.2.1171. Mol Cell Biol. 1999. PMID: 9891051 Free PMC article.

5

CMS: an adapter molecule involved in cytoskeletal rearrangements.

Kirsch KH, Georgescu MM, Ishimaru S, Hanafusa H. Kirsch KH, et al. Proc Natl Acad Sci U S A. 1999 May 25;96(11):6211-6. doi: 10.1073/pnas.96.11.6211. Proc Natl Acad Sci U S A. 1999. PMID: 10339567 Free PMC article.

6

The adapter type protein CMS/CD2AP binds to the proto-oncogenic protein c-Cbl through a tyrosine phosphorylation-regulated Src homology 3 domain interaction.

Kirsch KH, Georgescu MM, Shishido T, Langdon WY, Birge RB, Hanafusa H. Kirsch KH, et al. J Biol Chem. 2001 Feb 16;276(7):4957-63. doi: 10.1074/jbc.M005784200. Epub 2000 Nov 6. J Biol Chem. 2001. PMID: 11067845 Free article.

7

A p130Cas tyrosine phosphorylated substrate domain decoy disrupts v-crk signaling.

Kirsch K, Kensinger M, Hanafusa H, August A. Kirsch K, et al. BMC Cell Biol. 2002 Jul 15;3:18. doi: 10.1186/1471-2121-3-18. BMC Cell Biol. 2002. PMID: 12119061 Free PMC article.

8

Repression of BCL2 by the tumor suppressor activity of the lysyl oxidase propeptide inhibits transformed phenotype of lung and pancreatic cancer cells.

Wu M, Min C, Wang X, Yu Z, Kirsch KH, Trackman PC, Sonenshein GE. Wu M, et al. Among authors: kirsch kh. Cancer Res. 2007 Jul 1;67(13):6278-85. doi: 10.1158/0008-5472.CAN-07-0776. Cancer Res. 2007. PMID: 17616686

9

Activation of the focal adhesion kinase signaling pathway by structural alterations in the carboxyl-terminal region of c-Crk II.

Zvara A, Fajardo JE, Escalante M, Cotton G, Muir T, Kirsch KH, Birge RB. Zvara A, et al. Among authors: kirsch kh. Oncogene. 2001 Feb 22;20(8):951-61. doi: 10.1038/sj.onc.1204173. Oncogene. 2001. PMID: 11314030

10

A loss-of-function polymorphism in the propeptide domain of the LOX gene and breast cancer.

Min C, Yu Z, Kirsch KH, Zhao Y, Vora SR, Trackman PC, Spicer DB, Rosenberg L, Palmer JR, Sonenshein GE. Min C, et al. Among authors: kirsch kh. Cancer Res. 2009 Aug 15;69(16):6685-93. doi: 10.1158/0008-5472.CAN-08-4818. Epub 2009 Aug 4. Cancer Res. 2009. PMID: 19654310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66 results

Search Page

Filters